EMA's CHMP Offers Negative Opinion for Sickle Cell Drug Approved by US FDA - Regulatory Focus https://t.co/zza38Q9GGz — IDRO (@IDROOhio) May 30, 2019
EMA's CHMP Offers Negative Opinion for Sickle Cell Drug Approved by US FDA - Regulatory Focus https://t.co/zza38Q9GGz
No comments:
Post a Comment